background
despit
serious
denguerel
diseas
estim
million
case
dengu
fever
case
dengu
hemorrhag
feverdengu
shock
syndrom
year
clear
understand
dengu
pathogenesi
remain
elus
lack
diseas
model
anim
complex
immun
interact
dengu
infect
studi
host
respons
immunopathogenesi
difficult
develop
genom
technolog
microarray
high
throughput
quantit
pcr
allow
research
studi
gene
express
chang
much
broader
scale
therefor
use
approach
investig
host
respons
dengu
virusinfect
cell
line
patient
develop
dengu
fever
methodologyprincip
find
use
microarray
high
throughput
quantit
pcr
method
monitor
host
respons
dengu
viral
replic
cell
line
infect
model
dengu
patient
blood
sampl
identifi
differenti
express
gene
along
three
major
pathway
nfkb
initi
immun
respons
type
interferon
ifn
ubiquitin
proteasom
pathway
among
highli
upregul
gene
chemokin
itac
ligand
receptor
increas
express
itac
peripher
blood
ten
patient
earli
onset
fever
confirm
elisa
highli
upregul
gene
ifn
pathway
viperin
overexpress
cell
result
signific
reduct
viral
replic
upregul
gene
ubiquitinproteasom
pathway
prompt
test
proteasom
inhibitor
alln
reduc
viral
replic
conclusionsignific
unbias
gene
express
analysi
identifi
new
host
gene
associ
dengu
infect
valid
function
studi
show
part
host
respons
use
potenti
biomark
diseas
other
use
control
dengu
viral
replic
thu
repres
viabl
target
drug
therapi
although
denguerel
diseas
result
estim
million
case
dengu
fever
case
dengu
hemorrhag
feverdengu
shock
syndrom
year
clear
understand
dengu
pathogenesi
remain
elus
dengu
viru
envelop
positivestrand
rna
viru
flavivirida
famili
transmit
mosquito
aed
aegypti
aed
albopictu
four
serotyp
dengu
viru
circul
endem
area
although
infect
one
serotyp
dengu
viru
confer
lifelong
protect
immun
serotyp
protect
host
infect
serotyp
initi
target
cell
dengu
infect
believ
langerhan
cell
mean
yet
fulli
understood
langerhan
cell
spread
viru
via
lymphat
system
tissu
liver
spleen
kidney
blood
wherea
monocyt
macrophag
endotheli
cell
major
cell
type
viru
replic
major
symptomat
dengu
infect
fever
day
durat
develop
togeth
bone
joint
pain
retroorbit
pain
nausea
fatigu
call
dengu
fever
df
major
df
patient
recov
without
intervent
develop
sever
form
diseas
call
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
character
thrombocytopenia
vascular
leakag
caus
hypervolem
shock
death
promptli
treat
caus
dhfdss
clear
antibodi
depend
enhanc
ade
wide
support
theori
explain
higher
risk
dhfdss
associ
heterolog
secondari
infect
phenomenon
cell
origin
antigen
sin
also
describ
like
mani
virus
dengu
inhibit
ifna
ifnb
signal
suppress
jakstat
activ
result
reduc
host
antivir
respons
combin
reduc
host
defens
increas
uptak
viru
delay
viral
clearanc
like
synerg
produc
higher
viremia
result
sever
outcom
lack
diseas
model
anim
complex
immun
interact
dengu
infect
studi
host
respons
immunopathogenesi
difficult
develop
genom
technolog
allow
research
studi
gene
express
chang
much
larger
scale
summari
publish
microarray
data
infect
differ
host
cell
type
bacteria
virus
yeast
protozoa
helminth
reveal
common
hosttranscriptionalrespons
consist
cluster
ifnstimul
immun
mediat
gene
one
particularli
success
applic
microarray
technolog
identif
novel
drug
target
ckit
endotheli
cell
infect
kaposi
sarcomaassoci
herpesviru
kshv
regard
dengu
infect
gene
express
studi
carri
infect
human
umbil
vein
endotheli
cell
huvec
differenti
display
revers
transcript
ddrtpcr
affymetrix
oligonucleotid
microarray
gene
role
ifn
antivir
respons
immun
defens
oligoadenyl
synthetas
oa
myxoviru
protein
mxa
tnfa
phospholipid
scramblas
human
inhibitor
shown
upregul
upon
infect
infect
dengu
transform
huveclik
cell
line
analyz
differ
microarray
system
contain
cdna
oligonucleotid
studi
express
gene
involv
cell
cycl
apoptosi
membran
traffick
cytoskeleton
found
alter
infect
use
differ
gene
express
approach
primari
macrophag
infect
clinic
isol
dengu
analyz
cytokin
array
contain
human
cytokinerel
gene
approxim
gene
observ
either
upor
downregul
howev
function
import
chang
studi
use
compugen
human
oligonucleotid
array
studi
host
respons
dengu
infect
initi
human
hepatocyt
cell
line
identifi
upregul
three
major
cluster
gene
nfkbmediat
cytokinechemokin
respons
type
ifn
respons
ubiquitinproteasom
system
increas
express
select
gene
identifi
compugen
array
confirm
use
taqman
low
densiti
array
tlda
result
extend
includ
addit
readili
infect
cell
line
pbmc
deriv
adult
dengu
fever
patient
singapor
dengu
prospect
cohort
studi
next
sought
confirm
function
effect
upregul
gene
confirm
high
level
two
novel
chemokin
itac
dengu
infect
cell
line
dengu
patient
also
determin
overexpress
viperin
upregul
gene
ifn
pathway
proteasom
inhibit
alln
reduc
viru
replic
summari
use
microarray
analysi
identifi
new
host
gene
associ
dengu
infect
show
compon
host
respons
control
dengu
viral
replic
therefor
repres
potenti
target
drug
therapi
cell
line
hela
huvecc
obtain
atcc
maintain
instruct
type
dengu
viru
strain
obtain
dengu
outbreak
townsvil
australia
genbank
access
number
propag
cell
line
heatinactiv
viru
prepar
incub
viru
sampl
water
bath
hr
cell
line
infect
dengu
viru
multipl
infect
moi
hr
evalu
replic
effici
plaqu
assay
infect
cell
line
continu
beyond
hr
point
signific
degre
cell
death
becam
appar
cell
cultur
overnight
well
plate
media
remov
serial
dilut
viru
cultur
supernat
ad
individu
well
plate
incub
hr
media
aspir
replac
ml
methylcellulos
medium
fb
plate
incub
day
media
remov
cell
fix
formaldehyd
min
rins
water
stain
crystal
violet
min
rins
plaqu
count
manual
concentr
plaqu
form
unit
per
ml
pfu
ml
cell
cultur
supernat
calcul
drug
intervent
studi
cell
treat
compound
dmso
indic
concentr
time
cultur
supernat
collect
plaqu
assay
cytotox
cell
monitor
use
fluorescein
diacet
fda
acro
organ
belgium
mgml
ad
cell
min
room
temperatur
measur
use
fluoresc
plate
reader
nm
nm
emiss
dengu
eprotein
assess
suspens
cell
intracellular
stain
fluoresc
activ
cell
sorter
becton
dickinson
usa
conjug
alexafluor
conjug
kit
invitrogen
usa
monoclon
antibodi
atcc
cell
scrape
permeabil
use
bd
fac
permwash
solut
becton
dickinson
usa
acquisit
analysi
perform
use
cellquest
softwar
becton
dickinson
usa
dengu
preval
mosquitoborn
viral
diseas
affect
human
yet
present
drug
treatment
diseas
valid
host
target
therapeut
intervent
use
microarray
technolog
monitor
respons
virtual
everi
human
gene
aim
identifi
way
human
interact
dengu
viru
infect
order
discov
new
therapeut
target
could
exploit
control
viral
replic
activ
gene
identifi
three
pathway
common
vitro
vivo
infect
nfkb
initi
immun
pathway
type
interferon
pathway
ubiquitin
proteasom
pathway
next
found
inhibit
ubiquitin
proteasom
pathway
activ
type
interferon
pathway
result
signific
inhibit
viral
replic
howev
inhibit
nfkb
initi
immun
pathway
effect
viral
replic
suggest
drug
target
ubiquitin
proteasom
pathway
may
prove
effect
kill
dengu
viru
use
therapeut
improv
clinic
outcom
dengu
diseas
viru
quantif
real
time
rtpcr
rna
extract
infect
cell
use
rneasi
mini
kit
qiagen
netherland
dengu
serogroup
viru
detect
taqman
pcr
adapt
real
time
instrument
use
previous
publish
primer
probe
standard
abi
condit
use
incorpor
primer
quantif
achiev
relat
viral
ct
valu
ct
valu
standard
curv
measur
number
copi
bp
section
viru
forward
revers
clone
invitrogen
usa
human
array
oligonucleotid
probe
repres
gene
design
compugen
manufactur
sigmagenosi
use
accord
standard
protocol
describ
cdna
microarray
dye
swap
perform
sampl
everi
time
point
rigor
qualiti
check
perform
array
use
downstream
analysi
mer
oligonucleotid
probe
spot
onto
polyllysineco
microscop
slide
use
genemachin
omnigrid
microarray
spotter
usa
fluoresc
label
target
cdna
mg
total
rna
univers
human
refer
strategen
usa
experi
sampl
rna
extract
infect
cell
use
qiagen
rneasi
mini
kit
revers
transcrib
presenc
amersham
bioscienc
uk
use
superscript
revers
transcript
kit
invitrogen
usa
label
cdna
pool
concentr
resuspend
dig
easyhyb
roch
switzerland
buffer
hybrid
overnight
maui
hybrid
chamber
biomicro
usa
array
scan
use
genepix
scanner
axon
instrument
usa
gener
tiff
imag
imag
analyz
genepix
pro
softwar
axon
instrument
usa
measur
fluoresc
signal
intens
format
data
data
base
deposit
array
data
underw
lowess
normal
avail
r
packag
aroma
remov
channel
specif
bias
r
develop
core
team
differenti
express
gene
select
use
procedur
known
signific
analysi
microarray
sam
describ
brief
statist
use
sam
given
numer
group
mean
differ
standard
error
regular
constant
set
yield
tstatist
valu
call
fudg
constant
found
remov
trend
function
move
window
across
data
reduc
fals
posit
result
statist
tdistribut
signific
comput
use
permut
test
gene
comput
statist
larger
threshold
consid
signific
fals
discoveri
rate
fdr
associ
given
threshold
also
calcul
permut
data
quantit
pcr
qpcr
taqman
low
densiti
array
tlda
rna
extract
use
rnase
easi
kit
qiagen
netherland
infect
cell
patient
blood
sampl
see
patient
sampl
ml
blood
collect
paxgen
tube
rna
extract
use
paxgen
blood
rna
kit
preanalytix
qiagn
netherland
rna
subject
dnase
treatment
use
rnasefre
dnase
set
qiagen
netherland
ng
total
rna
revers
transcrib
use
highcapac
cdna
archiv
kit
abi
usa
process
taqman
micro
fluidic
card
compani
abi
usa
accord
manufactur
instruct
togeth
data
analysi
use
softwar
abi
usa
differenti
express
gene
detect
use
sam
analyz
sam
gene
list
use
appli
biosystem
onlin
program
panther
http
www
pantherdborg
pathway
interact
gene
onotolog
analysi
perform
use
metacor
version
genego
inc
usa
subject
enrol
earli
dengu
eden
studi
dengu
investig
conduct
primari
healthcar
clinic
singapor
local
ethic
approv
grant
inform
consent
patient
obtain
particip
requir
pcr
diagnosi
fever
durat
less
day
detail
pcr
diagnosi
see
enrol
dengu
case
either
serotyp
ten
dengu
posit
subject
n
male
select
repres
sever
case
dengu
criteria
platelet
count
x
ml
rang
mean
mean
age
year
rang
mean
fever
rang
first
visit
time
point
mean
durat
hour
rang
onset
fever
second
visit
time
point
occur
hour
first
visit
mean
fever
rang
dengu
neg
patient
enrol
criteria
fever
respiratori
infect
symptom
pcr
neg
dengu
ten
subject
taken
n
male
mean
age
year
old
rang
mean
fever
rang
mean
durat
hr
rang
first
visit
time
point
convalesc
sampl
collect
third
visit
week
later
time
point
time
point
ml
blood
sampl
collect
paxgen
tube
rna
analysi
ml
blood
sampl
collect
serum
separ
within
hr
store
serum
itac
concentr
measur
use
elisa
kit
r
system
per
manufactur
instruct
cell
transfect
express
construct
encod
viperin
use
lipofectamin
invitrogen
usa
cell
select
use
mgml
screen
viperin
express
immunoblot
cell
cultur
overnight
well
plate
ifnb
glycoferon
singapor
final
concentr
uml
ad
well
control
well
remain
untreat
twelv
hour
post
ifnb
treatment
cell
infect
dengu
viru
moi
hr
plaqu
assay
use
determin
viru
product
number
differ
cell
line
use
model
dengu
infect
clear
repres
appropri
model
analysi
host
respons
microarray
requir
high
rate
infect
screen
seven
human
cell
line
abil
support
replic
dengu
viru
use
clinic
dengu
serotyp
isol
access
number
strain
infect
human
cell
line
rank
maximum
plaqu
form
unit
pfu
ml
titer
produc
data
shown
result
obtain
wide
use
ngc
strain
data
shown
highest
yield
cell
line
lung
carcinoma
hepatoma
cell
line
use
studi
primari
focu
evid
liver
injuri
dhfdss
detect
dengu
antigen
hepatocyt
liver
microarray
identif
host
respons
dengu
viru
replic
use
infect
model
viral
replic
cell
infect
dengu
viru
hour
compar
heat
inactiv
viru
determin
plaqu
assay
viru
releas
cell
cultur
medium
figur
fac
analysi
infect
cell
label
intracellularli
alexa
antibodi
dengu
e
protein
figur
realtim
pcr
analysi
viral
rna
figur
three
method
show
new
viral
replic
began
hour
reach
plateau
hr
fac
analysi
show
cell
infect
point
hr
degre
cell
death
becom
appar
data
shown
experi
continu
analysi
microarray
perform
duplic
dyeswap
three
biolog
replic
time
point
compar
infecti
heat
inactiv
viru
use
sam
q
valu
fals
discoveri
threshold
reveal
significantli
differenti
express
gene
hr
post
infect
howev
transcript
identifi
hr
hr
total
transcript
repres
gene
tabl
differenti
express
hr
hr
cluster
transcript
use
panther
analysi
identifi
ifnmedi
immun
pathway
signific
p
valu
hr
gene
typic
induc
type
ifn
stimul
includ
oasl
ifih
ifnb
featur
promin
cluster
figur
tabl
analysi
gene
suggest
involv
nfkbmediat
cytokinechemokin
respons
nfkbib
itac
amongst
other
ubiquitin
relat
gene
other
figur
although
complet
overlap
core
host
respons
pathogen
involv
ifn
respons
nfkbmediat
immun
defens
respons
observ
array
result
gene
significantli
chang
includ
associ
cell
signal
lipid
metabol
cell
cycl
vesicular
transport
tabl
detect
significantli
regul
gene
system
microarray
data
deposit
public
databas
access
http
wwwncbinlm
nihgovprojectsgeo
access
number
evid
upregul
three
major
pathway
nfkb
ifn
ubiquitin
microarray
decid
pursu
pathway
confirm
valid
firstli
chose
gene
three
major
pathway
upregul
cell
line
shown
microarray
secondli
select
anoth
gene
function
associ
pathway
might
otherwis
associ
dengu
infect
taqman
low
densiti
array
lda
construct
gene
order
confirm
tabl
indic
high
rate
valid
gene
detect
microarray
order
exclud
gene
respons
specif
cell
line
alon
decid
test
express
level
gene
cell
line
use
lda
infect
model
plaqu
assay
reveal
peak
viral
product
occur
earlier
model
pfu
ml
hr
still
substanti
hr
postinfect
pfuml
quantit
pcr
also
reveal
higher
number
differenti
express
gene
gene
hr
time
point
gene
hr
time
point
tabl
seek
confirm
gene
relev
physiolog
set
sought
test
gene
dengu
patient
whole
blood
rna
sampl
obtain
ten
adult
fever
patient
age
year
old
enrol
singapor
earli
dengu
eden
cohort
studi
pcr
diagnos
posit
either
dengu
serotyp
show
typic
dengu
fever
symptom
second
visit
day
onset
fever
onset
fever
consid
day
platelet
count
drop
x
ml
rang
mean
admit
hospit
patient
sampl
test
express
select
gene
lda
gene
shown
differenti
express
compar
blood
sampl
taken
acut
fever
stage
first
visit
day
onset
fever
convalesc
third
visit
week
first
visit
tabl
confirm
express
certain
gene
two
differ
dengueinfect
cell
line
dengu
patient
tabl
colour
intens
deriv
mean
rel
express
fold
chang
dye
swap
result
comparison
univers
refer
strategen
usa
red
upregul
green
regul
black
chang
grey
miss
data
time
cours
select
upregul
least
one
time
point
cell
least
one
time
point
cell
dengu
patient
sampl
compar
acut
convalesc
blood
sampl
fifti
gene
fulfil
criteria
tabl
felt
repres
common
gene
involv
dengu
viru
respons
viru
replic
exclud
respons
cell
type
specif
common
gene
map
direct
interact
use
metacor
program
illustr
close
cluster
interconnected
network
gene
around
nfkb
tnfa
figur
nfkb
gene
alon
ad
network
despit
common
list
illustr
connect
induc
exampl
upregul
itac
vegf
could
link
activ
nfkb
two
feedback
control
gene
nfkb
activ
also
upregul
reflect
self
contain
activ
figur
degre
upregul
vari
gene
pathway
itac
highli
upregul
averag
express
two
cell
type
patient
gene
figur
number
gene
cluster
around
associ
ifn
pathway
examin
common
list
reveal
anoth
four
gene
viperin
relat
ifn
pathway
upregul
map
metacor
program
figur
final
number
gene
relat
ubiquitinproteasom
pathway
also
appear
metacor
map
sever
unmap
gene
appear
common
list
figur
two
highli
upregul
common
gene
nfkb
pathway
protein
itac
cell
chemoattract
figur
order
determin
upregul
gene
transcript
lead
translat
protein
releas
concentr
itac
protein
cell
cultur
supernat
follow
dengu
infect
determin
elisa
infect
model
dengu
infect
cell
produc
moder
signific
compar
heatinactiv
viru
treat
cell
concentr
figur
itac
figur
hr
earlier
time
point
data
shown
next
investig
nfkb
induc
protein
influenc
dengu
viru
replic
ad
dexamethason
infect
model
inhibit
nfkb
activ
prevent
itac
product
effect
viral
replic
data
shown
result
suggest
nfkb
activ
itac
product
direct
effect
viral
replic
rather
simpli
part
immun
respons
infect
serum
concentr
itac
ten
dengu
fever
patient
describ
togeth
ten
fever
patient
dengu
viral
pcr
neg
also
determin
elisa
high
concentr
figur
itac
figur
present
serum
dengu
fever
patient
significantli
serum
patient
first
day
fever
onset
second
day
fever
onset
visit
compar
convalesc
serum
p
p
respect
well
nondengu
fever
patient
serum
p
p
respect
itac
level
also
significantli
higher
first
visit
dengu
patient
serum
compar
convalesc
p
nondengu
fever
p
patient
itac
level
dengu
fever
patient
second
visit
significantli
lower
first
visit
fig
detect
larg
number
ifn
respons
gene
induc
cell
line
infect
dengu
patient
see
figur
studi
viperin
one
highli
upregul
gene
type
ifn
respons
pathway
viperin
previous
identifi
ifninduc
antivir
protein
hcmv
hcv
infect
order
investig
role
viperin
dengu
infect
use
establish
cell
line
stabli
overexpress
viperin
vip
compar
infect
wild
type
cell
wt
viperin
overexpress
cell
significantli
resist
viral
replic
shown
plaqu
assay
two
day
infect
figur
without
pretreat
ifnb
ifn
uml
although
pretreat
ifnb
greater
antivir
effect
viperin
express
alon
result
small
signific
reduct
viru
product
p
without
p
ifnb
pretreat
result
suggest
viperin
function
compon
ifnmedi
respons
dengu
demonstr
first
time
viperin
could
part
antidengu
respons
ubiquitin
anoth
pathway
identifi
list
common
gene
key
compon
immun
system
conjug
singl
multipl
ubiquitin
molecul
protein
target
defin
subcellular
local
destruct
proteasom
compon
ubiquitinproteasom
system
shown
requir
matur
releas
number
virus
see
review
order
investig
role
ubiquitinproteasom
system
dengu
infect
introduc
proteasom
inhibitor
alln
dengu
infect
model
lower
concentr
alln
significantli
reduc
viru
replic
cell
line
figur
examin
effect
compound
integr
viabil
inhibitortr
cell
use
fluorescein
diacet
reveal
cytotox
concentr
figur
higher
concentr
inhibitor
even
greater
effect
reduct
pfuml
degre
cytotox
figur
despit
fact
dengu
major
diseas
affect
tropic
world
littl
known
pathogenesi
due
partli
lack
suitabl
anim
model
complex
cell
interact
infect
individu
use
microarray
analysi
gene
express
high
throughput
quantit
realtim
pcr
investig
host
respons
dengu
infect
cell
line
df
patient
valid
microarray
result
function
studi
identifi
gene
although
dendrit
cell
langerhan
cell
monocyt
propos
principl
reservoir
viral
infect
clear
tissu
target
immunohistochemistri
insitu
hybridis
studi
biopsi
dhf
patient
indic
rang
tissu
infect
viru
includ
cell
liver
spleen
lung
kidney
peripher
blood
chose
cell
line
primari
cell
model
studi
readili
support
viral
replic
deriv
liver
might
clinic
relev
cell
line
includ
also
excel
support
viral
replic
even
though
presum
littl
clinic
relev
final
clinic
relev
came
valid
gene
df
patient
singapor
eden
cohort
patient
select
base
low
platelet
count
lack
dhfdss
manifest
singapor
adult
patient
despit
limit
sampl
number
wide
rang
collect
time
variat
individu
time
point
rule
statist
analysi
believ
patient
gene
differenti
express
would
identifi
overlap
upregul
gene
determin
quantit
pcr
two
cell
system
patient
remov
respons
uniqu
cell
type
fact
observ
cell
type
specif
gene
chang
rant
upregul
cell
line
patient
sampl
antiinflammatori
cytokin
upregul
patient
sampl
cell
line
indic
effect
multipl
cell
type
vivo
system
similarli
ifnb
upregul
cell
line
ifnc
patient
sampl
howev
larg
overlap
vitro
infect
patient
sampl
warrant
attent
two
highli
upregul
chemokin
itac
itac
ligand
chemokin
receptor
product
chemokin
lead
recruit
express
cell
nk
cell
increas
itac
express
seen
variou
viral
infect
especi
viral
mening
sar
patient
elev
earli
infect
shown
predictor
sever
outcom
neuron
shown
involv
recruit
cell
west
nile
viru
enceph
elev
itac
mrna
protein
also
found
liver
chronic
hepat
c
patient
dengu
infect
variou
chemokin
previous
found
induc
dengu
patient
includ
rant
itac
examin
see
review
dengu
intracerebr
mous
infect
model
mice
higher
mortal
rate
wild
type
mice
infect
indic
receptor
part
host
defens
mechan
like
recruit
cell
infect
site
also
propos
compet
viru
bind
receptor
vitro
howev
relev
studi
human
patient
clear
although
ifnc
ab
nfkb
could
induc
product
itac
prevent
itac
via
nfkb
inhibit
clearli
reduc
level
cell
furthermor
ifnb
ifnc
consist
upregul
two
cell
line
df
patient
studi
data
shown
therefor
believ
nfkb
activ
rather
ifn
induct
play
major
role
elev
itac
dengu
infect
inhibit
nfkb
consequ
itac
inhibit
demonstr
effect
dengu
replic
cell
line
suggest
complex
role
chemokin
multicellular
vivo
set
concentr
chemokin
significantli
higher
earli
stage
dengu
fever
itac
level
reduc
second
visit
level
remain
high
persist
high
level
might
also
contribut
immunopathogenesi
dengu
although
would
requir
investig
may
concentr
itac
combin
viral
antigen
could
use
earli
marker
dengu
fever
interest
note
level
itac
independ
previou
histori
dengu
infect
half
ten
test
patient
suffer
secondari
infect
common
clinic
featur
ten
select
patient
low
platelet
count
second
visit
lack
sever
dengu
case
definit
singapor
low
platelet
count
use
measur
sever
ten
patient
cohort
studi
classifi
sever
dengu
fever
point
make
link
level
itac
diseas
sever
small
number
case
use
studi
detail
clinic
studi
current
underway
aim
determin
concentr
itac
earli
stage
infect
link
progress
sever
form
diseas
abil
ifn
pretreat
inhibit
subsequ
dengu
replic
previous
report
import
ifn
antivir
respons
result
indic
viperin
one
highli
upregul
gene
model
follow
dengu
infect
viperin
encod
ifninduc
antivir
protein
shown
associ
endoplasm
reticulum
redistribut
golgi
apparatu
cytoplasm
vacuol
follow
human
cytomegaloviru
hcmv
infect
induct
viperin
suggest
antivir
hcmv
hepat
c
hcv
infect
first
associ
dengu
infect
use
viperin
overexpress
cell
demonstr
addit
significantli
upregul
infect
viperin
directli
involv
antivir
respons
dengu
shown
suppress
dengu
replic
presenc
increas
express
viperin
effect
signific
effect
ifnb
alon
suggest
viperin
part
ifnmedi
respons
dengu
molecular
mechan
action
viperin
counter
dengu
infect
need
studi
ubiquitinproteasom
system
cellular
machineri
involv
conjug
singl
multipl
ubiquitin
molecul
direct
protein
traffick
degrad
review
hcv
infect
ubiquitin
ligas
report
mediat
ubiquitin
degrad
viru
core
protein
hcv
polymeras
also
shown
interact
ubiquitinlik
protein
lead
degrad
dengu
ubiquitinproteasom
gene
report
involv
dengu
viru
life
cycl
although
recent
public
shown
dengu
envelop
protein
interact
conjug
enzym
overexpress
reduc
viru
product
cell
line
tlda
result
indic
signific
upregul
number
ubiquitinproteasom
system
relat
gene
dengu
viru
replic
unclear
respons
antivir
dengu
viru
utilis
compon
ubiquitinproteasom
system
replic
use
proteasom
inhibitor
alln
significantli
reduc
releas
dengu
viru
follow
infect
cell
line
previous
shown
effect
proteasom
inhibitor
may
viru
specif
compound
less
non
effect
viru
influenza
equin
infecti
anemia
viru
effect
proteasom
inhibit
viral
replic
appear
mediat
via
number
differ
process
includ
involv
ubiquitin
proteasom
viru
assembl
bud
releas
matur
studi
may
elucid
exact
role
ubiquitinproteasom
play
dengu
viru
replic
may
involv
traffick
viru
plasma
membran
matur
fusion
viru
upon
releas
instruct
compar
result
publish
microarray
studi
investig
host
respons
patient
blood
studi
identifi
gene
whose
protein
product
express
er
significantli
enrich
directli
overlap
identif
ubiquitin
pathway
specif
includ
psmb
gene
may
repres
process
fundament
viral
replic
system
addit
simmon
et
al
describ
host
respons
associ
dengu
shock
syndrom
clearli
overlap
interferon
relat
gene
list
particular
gene
oa
gene
ifi
gene
mx
gene
found
studi
suggest
amount
viral
replic
may
directli
relat
clinic
outcom
gene
array
number
cell
system
dengu
infect
reveal
mani
gene
host
respons
pathway
upregul
dengu
infect
function
analys
distinguish
host
respons
pathway
involv
initi
innat
signal
respons
nfkb
mediat
gene
ifn
pathway
involv
viru
replic
ubiquitinproteasom
system
specif
compon
respons
viru
viperin
itac
implic
dengu
infect
first
time
investig
compon
togeth
precis
role
ubiquitinproteasom
system
viru
replic
may
lead
drug
target
dengu
use
gene
array
multipl
cell
system
investig
gene
involv
viru
replic
use
concert
function
studi
prove
valid
approach
discoveri
novel
marker
gene
understand
host
respons
dengu
ultim
therapeut
dengu
tabl
microarray
gene
list
list
transcript
n
identifi
differenti
express
sam
analysi
respons
dengu
viru
compar
heat
inactiv
viru
hour
post
infect
transcript
place
group
accord
biolog
process
qv
sam
calcul
q
valu
gene
follow
sam
signific
select
base
delta
valu
calcul
varianc
sampl
set
see
materi
method
fc
indic
fold
chang
repres
signific
chang
gene
select
realtim
pcr
valid
taqman
low
densiti
array
tlda
platform
indic
tick
found
mb
doc
tabl
quantit
pcr
taqman
base
low
densiti
array
singapor
dengu
fever
patient
fold
increas
gene
express
determin
quantit
pcr
fold
chang
calcul
base
dengu
viru
infect
heatinactiv
viru
infect
dengu
fever
patient
patient
fold
chang
calcul
use
patient
blood
sampl
collect
first
visit
day
onset
fever
convalesc
week
acut
fever
upregul
shown
black
downregul
red
repres
signific
chang
signific
determin
q
valu
see
materi
method
gene
significantli
upregul
least
one
time
point
least
one
time
point
patient
indic
pvalu
calcul
standard
student
test
select
base
cut
found
mb
doc
